GO:0016554 cytidine to uridine editing: RNA Modification Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016554 cytidine to uridine editing is the enzymatic conversion of a cytosine residue to uridine in an RNA molecule by deamination.
• The reaction is catalyzed by cytidine deaminases such as APOBEC1 and related APOBEC family enzymes, often guided by auxiliary RNA-binding factors.
• Cytidine to uridine editing can create or destroy start or stop codons, alter splice sites, and change protein-coding potential, making it a key post-transcriptional regulatory layer.
• Plant RNA editing factors such as PPR78 and MORF8 are required for specific cytidine to uridine editing events and influence immunity and development.
• Programmable cytosine base editors and RNA base editors exploit cytidine deamination chemistry for targeted single-base editing without double-strand breaks.
• Dysregulated cytidine to uridine editing is linked to cancer, viral pathogenesis, and neurological disease models, making it a high-value target for functional genomics.
Description
Cytidine to uridine editing (GO:0016554) is a biological process in which a cytosine residue within an RNA molecule is converted to uridine through deamination. This reaction changes the informational content of RNA without altering the underlying DNA sequence, and it is one of the best-characterized forms of RNA editing in eukaryotes. The process is essential for generating protein isoform diversity, regulating RNA stability and translation, and shaping innate immune and stress responses. Researchers study cytidine to uridine editing because it sits at the intersection of RNA biology, gene regulation, and disease mechanisms, and because its chemistry has been repurposed for programmable base editing technologies. In plants, cytidine to uridine editing factors such as PPR78 and MORF8 control specific editing sites that affect development and immunity, demonstrating that this process is evolutionarily conserved and functionally important beyond mammals. In virology and neurobiology, integrative RNA profiling has revealed cytidine to uridine editing changes in neurons and astrocytes during viral infection, suggesting roles in host-pathogen interactions. Understanding GO:0016554 therefore requires knowledge of the deaminase enzymes, their guide factors, the RNA substrates they act on, and the downstream consequences for gene expression and disease.
cytidine to uridine editing At A Glance
| GO ID | GO:0016554 |
|---|---|
| GO term | cytidine to uridine editing |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Definition | The conversion of a cytosine residue to uridine in an RNA molecule by deamination |
| Major function | Post-transcriptional RNA sequence modification that alters coding and regulatory information |
| Representative enzymes | APOBEC1 and related cytidine deaminases, often with auxiliary RNA-binding factors |
| Representative substrates | mRNA, viral RNA, and other cellular RNAs containing editable cytosine residues |
| Related technologies | Cytosine base editors and RNA base editors that exploit cytidine deamination chemistry |
What Is GO:0016554?
GO:0016554 cytidine to uridine editing is defined as the conversion of a cytosine residue to uridine in an RNA molecule by deamination. In practical terms, an enzyme removes an amino group from the cytosine base of a ribonucleotide, producing uridine while leaving the RNA backbone intact. This is a post-transcriptional modification that can change codon identity, splicing patterns, and RNA structure, and it is distinct from DNA-level cytosine deamination because it occurs on RNA substrates.
Why Is cytidine to uridine editing Important in Cell Biology?
Cytidine to uridine editing is important because it expands the coding and regulatory capacity of the genome without changing DNA sequence, and because its dysregulation is associated with cancer, viral infection, and neurological disease models. The same deamination chemistry underpins programmable cytosine and RNA base editors, which are widely used for functional genomics and therapeutic development. In plants, cytidine to uridine editing factors regulate immunity and development, showing that this process is a conserved and broadly relevant regulatory mechanism.
• Creates protein diversity by changing codons in mRNA, including start and stop codons.
• Regulates RNA stability, structure, and translation efficiency through sequence changes.
• Contributes to innate immune and antiviral responses by editing viral and host RNAs.
• Is exploited by cytosine base editors for targeted single-base genome editing without double-strand breaks.
• Is exploited by RNA base editors for programmable single-base RNA editing.
• Plant cytidine to uridine editing factors such as PPR78 and MORF8 influence immunity and development.
• Dysregulated APOBEC-family deaminases are implicated in cancer pathogenesis, including cervical cancer.
• Provides a mechanistic basis for artificial MS2-APOBEC1 editing systems that restore genetic code.
• Serves as a model for studying enzyme-guided RNA substrate recognition and editing specificity.
• Offers a tractable target for functional screens and therapeutic intervention in RNA-driven diseases.
What Happens During cytidine to uridine editing?
Substrate recognition and guide factor assembly
In simple terms: First, the editing machinery finds the exact cytosine to change.
Cytidine to uridine editing begins with recognition of a target cytosine within an RNA substrate. In many systems, this is achieved by auxiliary RNA-binding factors that recruit a cytidine deaminase to the correct site. For example, plant PPR78 and MORF8 proteins are required for specific cytidine to uridine editing events, and PPR78 can retain function even after loss of known editing sites by targeting hidden extra sites. This step determines editing specificity and is a major focus of research because mis-targeting can alter unintended RNAs.
Cytosine deamination chemistry
In simple terms: The enzyme removes an amino group from cytosine, turning it into uridine.
The core chemical step is deamination of the cytosine base to produce uridine. APOBEC1 is the classic enzyme that performs cytidine to uridine conversion in apolipoprotein B mRNA, and related APOBEC family members share this catalytic activity. The reaction does not require DNA cleavage and operates directly on RNA, which is why it has been adapted for programmable base editing. The catalytic mechanism depends on the enzyme active site and on the local RNA sequence and structure context.
Editing site selection and specificity
In simple terms: Not every cytosine is edited; the machinery chooses specific sites.
Editing specificity is governed by cis-acting RNA sequences and trans-acting factors. In plants, PPR78 and MORF8 control distinct sets of cytidine to uridine editing sites, and loss of known sites can be compensated by hidden extra targets, indicating flexible but regulated site selection. In mammalian systems, APOBEC1 editing of apolipoprotein B mRNA is a paradigm for site-specific cytidine to uridine conversion. Artificial MS2-APOBEC1 systems have been developed to direct editing to chosen RNAs, demonstrating that guide-dependent targeting can restore or alter genetic code.
Downstream consequences for RNA and protein
In simple terms: After editing, the RNA message can code for a different protein or be handled differently by the cell.
Once a cytosine is converted to uridine, the RNA sequence changes, which can alter codons, splicing, RNA structure, and translation. In apolipoprotein B mRNA, cytidine to uridine editing creates a stop codon that yields a truncated protein isoform. In viral infection models, integrative RNA profiling of TBEV-infected neurons and astrocytes revealed editing changes that may act as pathogenic effectors. These downstream effects link cytidine to uridine editing to diverse cellular outcomes, including immunity, stress responses, and disease.
Regulation and dynamics of editing
In simple terms: Editing levels can go up or down depending on the cell state and signals.
Cytidine to uridine editing is dynamically regulated. APOBEC family enzymes are subject to transcriptional and post-transcriptional control, and their activity is linked to cancer pathogenesis, including cervical cancer. Plant editing factors such as MORF8 negatively regulate immunity to Phytophthora pathogens, showing that editing can be tuned during defense responses. In neurons and astrocytes, viral infection alters RNA editing profiles, indicating that editing is responsive to environmental and pathological cues.
Key Genes Involved in GO:0016554 cytidine to uridine editing
The following genes and proteins are central to cytidine to uridine editing, based on published literature on deaminases, guide factors, and editing-associated machinery.
| Gene | Major Role | Research Relevance |
|---|---|---|
| APOBEC1 | Catalyzes cytidine to uridine deamination in RNA, including apolipoprotein B mRNA | Classic model for RNA editing and base editor engineering |
| APOBEC3 family | Cytidine deaminases with antiviral and cancer-related functions | Implicated in cancer pathogenesis and innate immunity |
| APOBEC2 | Member of the APOBEC deaminase family | Studied for substrate specificity and family evolution |
| APOBEC4 | Member of the APOBEC deaminase family | Studied for catalytic and regulatory properties |
| AID/APOBEC | Related cytidine deaminases | Comparative models for deamination chemistry |
| PPR78 | Plant pentatricopeptide repeat protein required for specific cytidine to uridine editing | Demonstrates hidden extra targets and editing factor conservation |
| MORF8 | Plant multiple organellar RNA editing factor that negatively regulates immunity | Links cytidine to uridine editing to plant defense |
| MORF family | Auxiliary RNA editing factors in plants | Required for editing site recognition and complex assembly |
| MS2-APOBEC1 | Artificial editing system that directs APOBEC1 to target RNAs | Used to restore cytidine to uridine genetic code |
| TadA-derived deaminase | Engineered cytosine deaminase for programmable RNA editing | Enables single-base RNA editing without double-strand breaks |
| Cas13 | RNA-targeting CRISPR effector used with deaminases | Platform for programmable single-base RNA editing |
| APOBEC1 complementation factor | Auxiliary factor for APOBEC1-mediated editing | Supports site-specific apolipoprotein B mRNA editing |
| TBEV viral RNA | Viral RNA substrate subject to editing in infected cells | Model for editing in neurotropic viral infection |
| Host neuronal RNAs | Cellular RNAs whose editing changes during infection | Relevant to neuropathogenesis and host response |
| Cytosine base editor components | Fusion of deaminase and targeting module | Used for programmable DNA base editing based on deamination chemistry |
| RNA editing complex subunits | Accessory proteins that assemble with deaminases | Determine editing specificity and efficiency |
How Is cytidine to uridine editing Regulated?
Cytidine to uridine editing is regulated at multiple levels. Enzyme abundance and activity of APOBEC family deaminases are controlled transcriptionally and post-transcriptionally, and their dysregulation is linked to cancer pathogenesis. Auxiliary RNA-binding factors such as plant MORF8 and PPR78 determine which sites are edited and can modulate editing under immune challenge. In viral infection, editing profiles change in neurons and astrocytes, indicating that cellular state and pathogen signals influence editing activity. Artificial systems such as MS2-APOBEC1 show that targeting modules can redirect editing to chosen RNAs, providing a tool to study and manipulate regulation.
cytidine to uridine editing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| APOBEC3 family | Cervical cancer and APOBEC-driven mutagenesis | Cancer cell lines with APOBEC knockout or overexpression |
| APOBEC1 | RNA editing in apolipoprotein B metabolism | Hepatic cell models with APOBEC1 knockout or knock-in |
| MORF8 | Plant immunity to Phytophthora pathogens | Plant knockout lines and pathogen infection assays |
| PPR78 | Plant development and hidden RNA editing targets | Plant mutants and editing site profiling |
| TBEV-host editing axis | Neurotropic viral infection | Infected neuron and astrocyte cultures with RNA profiling |
Cancer and APOBEC-driven mutagenesis
APOBEC family cytidine deaminases are molecular drivers in cancer pathogenesis, including cervical cancer, where their deamination activity can contribute to mutagenesis and tumor evolution. Because cytidine to uridine editing shares catalytic chemistry with DNA cytosine deamination, understanding its regulation is important for interpreting APOBEC-related cancer signatures. Experimental models that manipulate APOBEC expression or activity can help dissect these contributions.
Viral infection and neuropathogenesis
Integrative RNA profiling of TBEV-infected neurons and astrocytes revealed changes in RNA editing that may act as pathogenic effectors. This suggests that cytidine to uridine editing participates in host-pathogen interactions in the central nervous system and may influence neuroinflammation or neuronal dysfunction. Model systems using infected neurons and astrocytes are valuable for studying these editing changes.
Plant immunity and crop biology
In plants, the cytidine to uridine RNA editing factor NbMORF8 negatively regulates immunity to Phytophthora pathogens, linking editing to defense signaling. PPR78 is conserved despite loss of known editing sites, explained by a hidden extra target, indicating that editing factors can have non-obvious functional roles. These findings make plant editing factors relevant to crop disease resistance research.
From cytidine to uridine editing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a deaminase abolish cytidine to uridine editing at specific sites? | Knockout cell model |
| Does a specific point mutation alter deaminase catalytic activity? | Point-mutation knock-in cell model |
| Can a disease-associated editing site be corrected? | Knock-in or base-edited cell model |
| Where and when is an editing factor expressed? | Tagged knock-in with imaging or proteomics |
| Does overexpression of a deaminase increase editing and downstream phenotypes? | Overexpression cell model |
| Which RNAs are edited under viral infection? | Infected neuron/astrocyte models with RNA-seq |
How to Study the cytidine to uridine editing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptome-wide C-to-U differences | Editing site discovery and quantification |
| Targeted RNA sequencing | Editing at specific candidate sites | Validation of editing events |
| In vitro deamination assay | Enzymatic conversion of cytosine to uridine | Deaminase activity and specificity |
| Reporter editing assay | Functional readout of editing | Testing guide and enzyme combinations |
| Cytosine base editing | Programmable C-to-U or C-to-T changes | Functional perturbation of editing sites |
| RNA base editing | Programmable single-base RNA changes | RNA-level editing and rescue experiments |
| Plant pathogen infection assay | Immune phenotype in editing factor mutants | Linking editing to plant immunity |
| Editing site profiling in mutants | Dependence of sites on specific factors | Defining factor-target relationships |
RNA sequencing and editing site detection
RNA-seq and targeted RNA sequencing are used to detect cytidine to uridine changes by comparing RNA reads to the reference genome and identifying C-to-U differences. Integrative RNA profiling in TBEV-infected neurons and astrocytes demonstrated how editing changes can be mapped in disease-relevant models. These methods are essential for defining the editome and for validating candidate editing sites.
Functional assays for deaminase activity
Reporter assays and in vitro deamination assays measure the catalytic activity of APOBEC1 and related enzymes on defined RNA substrates. Artificial MS2-APOBEC1 systems allow targeted editing and readout of restored genetic code, providing a controlled functional assay. Such assays help distinguish direct editing effects from downstream consequences.
CRISPR-based base editing readouts
Cytosine base editors and RNA base editors use deaminase chemistry to install or reverse C-to-U changes in a programmable manner. These systems enable precise perturbation of editing sites and can be paired with sequencing to quantify editing efficiency and specificity. They are widely used to test causal roles of specific editing events.
Plant genetics and pathogen assays
In plants, knockout and mutant lines for editing factors such as MORF8 and PPR78 are used with pathogen infection assays to link cytidine to uridine editing to immunity and development. Editing site profiling in these mutants reveals which sites depend on which factors. These approaches illustrate how genetic models can dissect editing factor function.
How CRISPR Can Be Used to Study GO:0016554 cytidine to uridine editing
Knockout
CRISPR knockout of deaminases or auxiliary editing factors can abolish specific cytidine to uridine editing events and reveal their downstream functions. For example, knocking out plant MORF8 or PPR78 alters editing at target sites and changes immunity or development phenotypes. In mammalian cells, knockout of APOBEC1 or related enzymes provides a clean background to test editing dependence.
Point Mutation
Point mutations in deaminase catalytic residues or in RNA cis-elements can dissect the mechanism of cytidine to uridine editing. CRISPR-mediated point-mutation models allow researchers to test whether a specific residue is required for deamination or for substrate recognition. Such models are valuable for separating catalytic activity from targeting functions.
Knock-in
Knock-in of tagged editing factors or of reporter RNAs enables visualization and quantification of cytidine to uridine editing in living cells. Tagged knock-in models can be combined with imaging or proteomics to determine where and when editing complexes assemble. Knock-in of disease-relevant editing sites can also be used to test correction strategies.
Overexpression
Overexpression of APOBEC family deaminases or plant editing factors can increase editing at target sites and amplify downstream phenotypes. Overexpression models are useful for identifying new editing targets and for testing whether increased editing contributes to disease or immunity. They can also be used to validate artificial editing systems such as MS2-APOBEC1.
How EDITGENE Supports cytidine to uridine editing Research
Researchers studying cytidine to uridine editing-related genes often need to determine whether a candidate gene is causally involved in a specific editing event, disease phenotype, or immune response. Building reliable knockout, point-mutation, knock-in, and overexpression models is therefore essential for moving from correlation to mechanism. EDITGENE provides these models and the associated screening and bioinformatics support to accelerate functional studies of GO:0016554.
Contact EDITGENE today to design your custom CRISPR model for cytidine to uridine editing research.
Frequently Asked Questions About cytidine to uridine editing
What is cytidine to uridine editing?
Cytidine to uridine editing (GO:0016554) is the conversion of a cytosine residue to uridine in an RNA molecule by deamination.
What genes are involved in cytidine to uridine editing?
Key genes include APOBEC1 and other APOBEC family deaminases, as well as plant editing factors such as PPR78 and MORF8.
Which enzyme catalyzes cytidine to uridine editing?
APOBEC1 is a classic enzyme that catalyzes cytidine to uridine conversion in apolipoprotein B mRNA, and related deaminases share this activity.
How is cytidine to uridine editing detected?
It is detected by RNA sequencing and targeted RNA sequencing that identify C-to-U differences compared with the reference sequence.
Why is cytidine to uridine editing important in cancer?
APOBEC family deaminases are molecular drivers in cancer pathogenesis, including cervical cancer, linking deamination activity to mutagenesis.
Can CRISPR be used to study cytidine to uridine editing?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models can test the roles of deaminases and editing factors.
What is the relationship between cytidine to uridine editing and base editors?
Cytosine base editors and RNA base editors exploit cytidine deamination chemistry for programmable single-base editing.
Is cytidine to uridine editing conserved in plants?
Yes, plant factors such as PPR78 and MORF8 are required for specific cytidine to uridine editing events and affect immunity and development.
What happens if cytidine to uridine editing is dysregulated?
Dysregulation can alter RNA coding potential and is associated with cancer, viral infection, and neurological disease models.
How can I model cytidine to uridine editing in the lab?
You can use knockout, point-mutation, knock-in, overexpression, and CRISPR screening models, often combined with RNA-seq and reporter assays.
Conclusion
Cytidine to uridine editing (GO:0016554) is a fundamental RNA modification that changes genetic information post-transcriptionally through deamination. Its roles span protein diversity, immunity, viral infection, and cancer, and its chemistry underpins modern base editing technologies. Studying this process requires integrated genetic, biochemical, and computational approaches, and well-designed CRISPR models are essential for establishing causality. EDITGENE supports this work with knockout, point-mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to cytidine to uridine editing research.
References
- 1. Komor AC et al.. 2016. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.. Nature 533(7603):420-4 PMID: 27096365
- 2. Revathidevi S et al.. 2021. APOBEC: A molecular driver in cervical cancer pathogenesis.. Cancer Lett 496:104-116 PMID: 33038491
- 3. Chester A et al.. 2000. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.. Biochim Biophys Acta 1494(1-2):1-13 PMID: 11072063
- 4. Yang Y et al.. 2020. Cytidine-to-Uridine RNA Editing Factor NbMORF8 Negatively Regulates Plant Immunity to Phytophthora Pathogens.. Plant Physiol 184(4):2182-2198 PMID: 32972981
- 5. Abudayyeh OO et al.. 2019. A cytosine deaminase for programmable single-base RNA editing.. Science 365(6451):382-386 PMID: 31296651
- 6. Selinger M et al.. 2022. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.. Comput Struct Biotechnol J 20:2759-2777 PMID: 35685361
- 7. Bhakta S et al.. 2025. Restoration of cytidine to uridine genetic code using an MS2-APOBEC1 artificial enzymatic approach.. Methods Enzymol 713:271-285 PMID: 40250957
- 8. Lesch E et al.. 2024. Conservation of the moss RNA editing factor PPR78 despite the loss of its known cytidine-to-uridine editing sites is explained by a hidden extra target.. Plant Cell 36(3):727-745 PMID: 38000897
